-
In the Moment- Spring 2016
Colleen Bokor, Dana Stewart, Brittany Avin.
-
The High-Deductible Gamble
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
-
Survivor Profile
Changing CourseDuring her treatment for breast cancer, biomedical engineer Jessica Winter challenged her laboratory to bring its discoveries to patients more quickly.
by Chris Palmer
-
Yesterday & Today
A Storied LifeLiterary realist John Updike used the scaffold of his own life, including his lung cancer diagnosis, to explore the shared experiences of our time.
by Sue Rochman
-
Honor Your Body
Coming to terms with feelings and emotions about weight gain and weight loss is often part of a cancer patient's experience.
by Sue Rochman
-
In the Moment- Winter 2015/2016
Jared Levinthall, Carol Dellinger, Anne Ha.
-
Breaking the Blood-Brain Barrier
Advances in treating brain metastases and reducing their side effects are bringing new hope to cancer patients.
by Sue Rochman
-
Survivor Profile
Stop the SilenceCancer survivor Cherry Sloan-Medrano works to encourage a conversation about cancer among Asians in the U.S.
by Jenny Song
-
Colorectal Cancer: A Troubling Trend
More people are being diagnosed with colorectal cancer before 50, the recommended age to start screening.
by Charlotte Huff
-
The Work-Cancer Balance
Some patients want to work through illness and others need to, but juggling work responsibilities and treatment regimens can be a challenge.
by Leigh Labrie
Cancer Talk
Online Second Opinions
More than half of patients who participated in a program offering online second opinions were recommended a change to their treatment plan.
by Eric Fitzsimmons
Musical Toxicity an Effect of Cancer TreatmentStudy finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
Treatment Lags Behind Guidelines for Many Men With Prostate CancerGuidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi Gilmore
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon